Short Interest in Longevity Health Holdings, Inc. (NASDAQ:XAGE) Increases By 358.0%

Longevity Health Holdings, Inc. (NASDAQ:XAGE) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 40,300 shares, a growth of 358.0% from the August 31st total of 8,800 shares. Based on an average trading volume of 81,800 shares, the days-to-cover ratio is presently 0.5 days. Based on an average trading volume of 81,800 shares, the days-to-cover ratio is presently 0.5 days.

Hedge Funds Weigh In On Longevity Health

A hedge fund recently bought a new stake in Longevity Health stock. Bank of Montreal Can bought a new position in shares of Longevity Health Holdings, Inc. (NASDAQ:XAGE) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,000 shares of the company’s stock, valued at approximately $30,000. Bank of Montreal Can owned about 1.20% of Longevity Health as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Longevity Health from a “sell” rating to a “hold” rating in a report on Saturday, August 9th.

Longevity Health Price Performance

XAGE opened at $0.61 on Thursday. Longevity Health has a 1-year low of $0.61 and a 1-year high of $38.10. The stock has a 50 day moving average price of $2.24.

Longevity Health (NASDAQ:XAGE) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($1.56) EPS for the quarter. The firm had revenue of $0.50 million for the quarter.

Longevity Health Company Profile

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing.